Announcements Trials
Browse Landscape

Phase

Phase 2 16Phase 3 10Phase NA 4Phase 1/2 2Phase 2/3 1Phase 1 1

Status

Withdrawn 1Completed 1

Sponsor Class

INDUSTRY 181OTHER 163NIH 13OTHER_GOV 2NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Carcinoma, Non-Small-Cell Lung 10Breast Neoplasms 9Central Nervous System Neoplasms 8Multiple Myeloma 7Lung Neoplasms 7Leukemia, Myeloid, Acute 6Ovarian Neoplasms 5Uterine Cervical Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Non-Hodgkin 4Leukemia 4Gliosarcoma 4Glioblastoma 4Burkitt Lymphoma 4Squamous Cell Carcinoma of Head and Neck 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Congenital Abnormalities 3Colorectal Neoplasms 3Stomach Neoplasms 2Small Cell Lung Carcinoma 2Recurrence 2Radiation Injuries 2Pancreatic Neoplasms 2Osteosarcoma 2Oligodendroglioma 2Neuroblastoma 2Myelodysplastic Syndromes 2Lymphoma 2Leukemia, Myelomonocytic, Acute 2Leukemia, Monocytic, Acute 2

Interventions

Gemcitabine 2saracatinib 1conatumumab 1Radiotherapy, Conformal 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × NETWORK × Pancreatic Neoplasms × Clear all
NCT00265876 2023-08-04

AZD0530 and Gemcitabine in Locally Advanced/Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery

Canadian Cancer Trials Group

Phase 1/2 Completed
34 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT01017822 2013-06-24

Conatumumab, Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer

Radiation Therapy Oncology Group

Phase 1/2 Withdrawn
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡